SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-22-073894
Filing Date
2022-06-23
Accepted
2022-06-23 16:05:32
Documents
2
Period of Report
2022-06-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2218989-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2218989-1_3seq1.xml 3 7182
2 EXHIBIT 24 tm2218989d1_ex24.htm EX-24 8732
  Complete submission text file 0001104659-22-073894.txt   17478
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5 RADNOR CORPORATE CENTER, SUITE 500 100 MATSONFORD ROAD RADNOR PA 19087
Business Address
Shafer Christina (Reporting) CIK: 0001934412 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36576 | Film No.: 221035458